Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography

Journal of Nuclear Medicine

Volumn 45, Issue 4, 2004, Pages 673-681

  Lin, Kun Ju ^a,b   Yen, Tzu Chen ^b   Wey, Shiaw Pyng ^a   Hwang, Jeng Jong ^c   Ye, Xin Xian ^c   Tzen, Kai Yuan ^b   Fu, Ying Kai ^d   Chen, Jin Chung ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

Author keywords

Biodistribution; Quantitative autoradiography; Serotonin transporter

Indexed keywords

2 ((2 ((DIMETHYLAMINO)METHYL)PHENYL)THIO) 5 IODOPHENYLAMINE I 123; CHLORAMPHETAMINE; SEROTONIN TRANSPORTER; TRACER; UNCLASSIFIED DRUG; 2 ((2 ((DIMETHYLAMINO)METHYL)PHENYL)THIO) 5 IODOPHENYLAMINE; 2-((2-((DIMETHYLAMINO)METHYL)PHENYL)THIO)-5-IODOPHENYLAMINE; BIOGENIC AMINE; CARRIER PROTEIN; CINANSERIN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SLC6A4 PROTEIN, MOUSE; SLC6A4 PROTEIN, RAT;

ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN REGION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SPECIFICITY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; PROTEIN BINDING; RAT; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BIOGENIC AMINES; BRAIN; CARRIER PROTEINS; CINANSERIN; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; P-CHLOROAMPHETAMINE; PROTEIN BINDING; RADIOPHARMACEUTICALS; RATS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TISSUE DISTRIBUTION;

EID: 2542427714     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kasper S, Tauscher J, Willeit M, et al. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder: implications for psychopharmacology. World J Biol Psychiatry. 2002;3:133-146.
2. Scheffel U, Dannals RF, Suehiro M, et al. Development of PET/SPECT ligands for the serotonin transporter. NIDA Res Monogr. 1994;138:111-130.
3. 125I-ADAM to serotonin transporters in rat brain. Synapse. 2000;38:403-412.
4. Oya S, Choi SR, Hou C, et al. 2-((2-((dimethylamino)methyl)phenyl)thio)- 5-iodophenylamine (ADAM): an improved serotonin transporter ligand. Nucl Med Biol. 2000;27:249-254.
5. 123I-ADAM and SPECT. J Nucl Med. 2001;42:1556-1562.
6. 123I-ADAM in mice: correlation with whole body autoradiography. Nucl Med Biol. 2002;29:643-650.
7. 123I]ADAM in healthy human subjects: preliminary results. Eur J Nucl Med Mol Imaging. 2003;30:132-136.
8. Sur C, Betz H, Schloss P. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience. 1996;73:217-231.
9. Charon Y, Laniece P, Tricoire H. Radio-imaging for quantitative autoradiography in biology. Nucl Med Biol. 1998;25:699-704.
10. Johnston RF, Pickett SC, Barker DL. Autoradiography using storage phosphor technology. Electrophoresis. 1990;11;355-360.
11. 14C. Biol Pharm Bull. 1995;18:89-93.
12. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. Burlington, MA: Academic Press; 1998.
13. 11C- nemonapride. Nucl Med Biol. 1999;26:291-296.
14. Ichise M, Meyer JH, Yonekura Y. An introduction to PET and SPECT neuroreceptor quantification models. J Nucl Med. 2001;42:755-763.
15. Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA. 1993;90:2542-2546.
16. Pletscher A, Burkhard WP, Bruderer H, Gey KF. Decrease of cerebral 5-hydroxytryptamine and 5-hydroxy-indoleacetic acid by an arylalkylamine. Life Sci. 1963;11:828-833.
17. Vorhees CV, Schaefer GJ, Barrett RJ. p-Chloroamphetamine: behavioral effects of reduced cerebral serotonin in rats. Pharmacol Biochem Behav. 1975;3:279-284.
18. Mamounas LA, Molliver ME. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp Neurol. 1988;102:23-36.
19. Fuller RW. Effects of p-chloroamphetamine on brain serotonin neurons. Neurochem Res. 1992;17:449-456.